No Data
No Data
ITeos Therapeutics Price Target Maintained With a $21.00/Share by HC Wainwright & Co.
H.C. Wainwright Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Cuts Target Price to $21
Express News | HC Wainwright & Co. Reiterates Buy on ITeos Therapeutics, Maintains $21 Price Target
Strategic Focus on Belrestotug Drives Buy Rating for ITeos Therapeutics With Adjusted Price Target of $21
Express News | Iteos Therapeutics Inc : Piper Sandler Cuts Target Price to $16 From $36
ITeos Therapeutics Says Deprioritizing Cancer Drug Candidate Inupadenant